Pohlmann v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-46292 |
| Nature of Suit | 470 Other Statutes - Racketeer Influenced and Corrupt Organizations |
| Cause | 28:1332 Diversity-Racketeering (RICO) Act |
| Case Filed: | Dec 03, 2018 |
| Case in other court: | Louisiana Eastern, 2:18-cv-09557 |
| Last checked: Friday Nov 08, 2019 6:57 PM EST |
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Wal-Mart
|
|
|
Defendant
WALGREEN CO.
200 WILMOT ROAD
DEERFIELD, IL 60015 |
|
|
Defendant
Top Rx, Inc.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals Industries Ltd.
|
Represented By
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Frederick Company Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Noramco Inc
|
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
Associated Pharmacies, Inc.
|
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
Indivior, Inc.
|
Represented By
|
|
Defendant
Insys Therapeutics Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
|
|
Defendant
Janssen Pharmaceutical, Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Mallinckrodt LLC
|
|
|
Plaintiff
James Pohlmann
|
Represented By
|
| Docket last updated: 04/08/2019 9:00 PM EDT |
| Monday, October 15, 2018 | ||
| 1 | 1
NOTICE OF REMOVAL from 34th Judicial District Court, St. Bernard Parish, case number 18-1218 A (Filing fee $ 400 receipt number 053L-7172178) filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson.Attorney Kelly Juneau Rookard added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney Kelly Juneau Rookard added to party Johnson & Johnson(pty:dft).(Rookard, Kelly) Modified text on 10/16/2018 (am). (Attachment 3 replaced on 10/16/2018) (am). [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Civil Cover Sheet,
|
||
|
Att: 2
Exhibit 1,
|
||
|
Att: 3
Exhibit 2,
|
||
|
Att: 4
Collateral Pleadings Notice
|
||
| 2 | 2 Initial Case Assignment to Judge Sarah S. Vance and Magistrate Judge Michael North. (cc) [Transferred from laed on 12/3/2018.] | |
| Tuesday, October 16, 2018 | ||
| 3 | 3 Correction of Docket Entry by Clerk re1 Notice of Removal,**Exhibit 2 was imaged as 8-1/2" x 14". All documents should be 8-1/2" x 11". Clerk has corrected the image.** (am) [Transferred from laed on 12/3/2018.] | |
| 4 | 4
Directive of the Clerk regarding compliance with 28:1447(b) re1 Notice of Removal, filed by Janssen Pharmaceuticals, Inc, Johnson & Johnson. By the Clerk.(am) [Transferred from laed on 12/3/2018.]
|
|
| Friday, October 19, 2018 | ||
| 5 | 5
EXPARTE/CONSENT MOTION for Extension of Time to Answer or Otherwise File Responsive Pleadings as to all Manufacturing Defendants by Janssen Pharmaceuticals, Inc., Johnson & Johnson.(Rookard, Kelly) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Monday, October 22, 2018 | ||
| 6 | 6
ORDER Granting as Modified5 Motion for Extension of Time to Answer or Otherwise File Responsive Pleadings as to all Manufacturing Defendants up to and until thirty (30) days following the JPML's decision on transfer, or if transfer is denied, a ruling of this Courtregarding remand, should Plaintiff move to remand. Signed by Judge Sarah S. Vance on 10/22/2018. (am) [Transferred from laed on 12/3/2018.]
|
|
| Monday, October 29, 2018 | ||
| 7 | 7
NOTICE by McKesson Corporation Supplemental Notice of Removal .(Williams, Stacey) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Exhibit
|
||
| 8 | 8
Statement of Corporate Disclosure by McKesson Corporation (Williams, Stacey) [Transferred from laed on 12/3/2018.]
|
|
| 9 | 9
Notice of Related Case(s) by McKesson Corporation. (Williams, Stacey) [Transferred from laed on 12/3/2018.]
|
|
| 10 | 10
EXPARTE/CONSENT MOTION for Extension of Deadlines by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation.(Williams, Stacey) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Tuesday, October 30, 2018 | ||
| 11 | 11 Correction of Docket Entry by Clerk re10 MOTION for Extension of Deadlines ,8 Statement of Corporate Disclosure,9 Notice of Related Case(s),7 Notice. **Name of attorney who electronically filed this document does not match name of signatory attorney on pleading. The user log-in and password serve as the required signature for purposes of Rule 11 of the FRCP. No further action is necessary.** (am) [Transferred from laed on 12/3/2018.] | |
| 12 | 12
ORDER granting as Modified10 Motion for Extension of Deadlines. Signed by Judge Sarah S. Vance on 10/30/2018. (am) [Transferred from laed on 12/3/2018.]
|
|
| 13 | 13
Notice of Compliance1 Notice of Removal with 28 U.S.C. § 1447(b) by Janssen Pharmaceuticals, Inc., Johnson & Johnson re4 Order.(Rookard, Kelly) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
State Court Pleadings
|
||
| 14 | 14
Statement of Corporate Disclosure by Janssen Pharmaceuticals, Inc., Johnson & Johnson. Janssen Pharmaceuticals, Inc. identifying Corporate Parent Janssen Pharmaceutica Inc., Corporate Parent Ortho-McNeil-Janssen Pharmaceuticals, Inc., Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. (Rookard, Kelly) Modified text on 10/31/2018 (am). [Transferred from laed on 12/3/2018.]
|
|
| Wednesday, October 31, 2018 | ||
| 15 | 15
MOTION to Remand to State Court by James Pohlmann. Motion(s) will be submitted on 11/21/2018.(Leger, Walter) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Memorandum in Support,
|
||
|
Att: 2
Notice of Submission,
|
||
|
Att: 3
Proposed Order
|
||
| 16 | 16
Request/Statement of Oral Argument by James Pohlmann regarding15 MOTION to Remand to State Court (Leger, Walter) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Thursday, November 01, 2018 | ||
| 17 | 17
ORDER denying16 Request/Statement of Oral Argument. Signed by Judge Sarah S. Vance on 11/1/2018.(cg) [Transferred from laed on 12/3/2018.]
|
|
| Friday, November 02, 2018 | ||
| 18 | 18
EXPARTE/CONSENT MOTION to Continue Hearing on Plaintiff's Motion for Remand by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKesson Corporation.(Williams, Stacey) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Monday, November 05, 2018 | ||
| 19 | 19
ORDER granting18 MOTION to Continue Hearing on Plaintiff's Motion for Remand . Motion for Remand is continued to February 27, 2019 without oral argument. Signed by Judge Sarah S. Vance on 11/05/2018.(am) [Transferred from laed on 12/3/2018.]
|
|
| Friday, November 30, 2018 | ||
| 20 | 20
Notice of Conditional Transfer Order from MDL Panel regarding MDL 2804. (jeg) [Transferred from laed on 12/3/2018.]
|
|
| 21 | 21
Order of MDL Transfer to District of Ohio Northern. MDL case number is 2804. Electronic file, certified copy of transfer order, and docket sheet sent.(jeg) [Transferred from laed on 12/3/2018.]
|
|
|
Att: 1
Transmittal Letter
|
||
| Monday, December 03, 2018 | ||
| 22 | 22
CASE TRANSFERRED IN from District of Louisiana Eastern. Case number 2:18-cv-09557. Original file, certified copy of transfer order and docket sheet received.
|
|